Post-polio syndrome …

Summer B Gibson MD

Infectious Disorders

Updated 01.09.2024
Released 09.09.2003
Expires For CME 01.09.2027

Post-polio syndrome

Author: Summer B Gibson MD

See Contributor Disclosures

Editor: John E Greenlee MD

Post-polio syndrome

In This Article

Quick Link

Introduction

Overview

In post-polio syndrome, symptoms typically occur several decades after recovery, after a long latent period. In addition to motor symptoms, many patients experience nonmotor manifestations, including cognitive symptoms, pain, and fatigue. Use of pharmacological agents in post-polio syndrome has, thus far, been disappointing. It is hoped that support from a polio clinic may result in self-selected lifestyle changes, which may positively influence the development of symptoms and functional capacity. Patient education, health promotion, screening, sleep management, and energy conservation strategies that include walking with a properly fitting assistive device reduce perceived fatigue and improve posture and function in an individual with post-polio syndrome.

Key points

	• The post-polio population is aging and decreasing in size. Still, thousands of post-polio patients require skilled nursing care with their advancing age and declining function.
	• Fatigued post-polio patients can be considered a distinct subgroup across the fatigue continuum.
	• Diaphragmatic paralysis in post-polio syndrome can be unilateral or bilateral. When unilateral, the prognosis is good, but bilateral diaphragmatic paralysis often has a worse prognosis.
	• Supportive care, self-selected lifestyle changes, and energy conservation strategies remain the main axiom of therapy.
	• Post-polio patients are at a high risk for falls and fractures.

Historical note and terminology

Poliomyelitis epidemics in the United States came to an abrupt end with the introduction of the inactivated poliomyelitis vaccine (Salk Vaccine) in 1955 and the live attenuated oral polio vaccine (Sabin Vaccine) in 1961 (131; 38). Even though poliomyelitis has been eliminated in much of the world, many patients from prior epidemics were left with severe sequelae and disabilities. These patients became over-achievers by working hard both physically and emotionally to overcome their disabilities (176). Now, many decades after contracting acute poliomyelitis, these survivors are developing new symptoms, collectively referred to as “late effects of poliomyelitis” or the “post-polio syndrome.” Not only are there new physical disabilities with which to cope, but also psychological effects of a second disability from a disease presumably resolved.

The syndrome of late weakness occurring many years after acute poliomyelitis has been recognized for over 100 years. However, it did not receive general public recognition until the large number of cases began to be seen in the 1980s (11; Halstead and 176). In 1875, late weakness occurring years after poliomyelitis was noted by Charcot and other clinicians (35; 45; 141). Between 1875 and 1975 only about 200 cases of post-polio syndrome were described in publications (90). However, since 1975 thousands of cases have been reported (79; 90; 173; 92; 105).

Energized by hope and optimism, the mid-1980s and early 1990s saw a surge of support groups (maximum of 298 in 1990) and clinics (96 in 1990), followed by a steady decline (131 support groups and 32 clinics in 2010) as the limits of research as well as clinical and self-help initiatives became obvious. Also, the post-polio population is aging and decreasing in size. Still, thousands of post-polio patients require skilled nursing care with their advancing age and declining function (76).

Clinical manifestations

Presentation and course

Post-polio syndrome is manifested by neurologic, musculoskeletal, and systemic symptoms and signs. The most prominent neurologic manifestation is new progressive weakness, sometimes accompanied by muscle atrophy. When this occurs in an extremity, it has been referred to as post-polio progressive muscular atrophy. However, new weakness can also affect respiratory and bulbar muscles (51; 90). The diagnostic criteria for post-polio progressive muscular atrophy have been derived from the criteria first promulgated by Mulder and colleagues (120), which were updated by the Post-Polio Task Force (92). This includes four criteria: (1) A prior episode of paralytic poliomyelitis with residual motor neuron loss (which can be confirmed through a typical patient history, a neurologic examination, and, if needed, electromyography); (2) A period of neurologic recovery followed by an interval (usually 15 years or more) of neurologic and functional stability; (3) A gradual or abrupt onset of new weakness or abnormal muscle fatigue, decreased endurance, muscle atrophy, or generalized fatigue; and (4) Exclusion of medical, orthopedic, and neurologic conditions that may be causing the symptoms mentioned in number 3.

Neurologic manifestations. New, slowly progressive muscle weakness is the most important neurologic problem (Table 1), occurring in most post-polio syndrome patients (41; 77; 91). It appears to be related to a disintegration of the lower motor neuron unit (motor unit) (36; 50) and can occur in muscles previously affected and partially or fully recovered or in muscles previously unaffected (77; 91). Electromyography (EMG) (81) and animal studies (25; 145) indicate that some clinically unaffected muscles were involved subclinically during acute poliomyelitis. However, previously affected muscles are more likely than unaffected muscles to later become weak (77; 91). The distribution of the new weakness appears to correlate with the severity of paralysis at the time of the acute poliomyelitis and, thus, with the number of surviving motor neurons (24; 36). Studies by Wendebourg and colleagues, employing 3T axial 2D-rAMIRA MR-imaging, indicated that functional decline in post-polio syndrome is accompanied by progressive atrophy of spinal cord gray matter (174). These authors concluded that functional decline in post-polio syndrome was the result of a secondary neurodegenerative process, which was not explained by aging or residuals of the initial infection alone (174).

Table 1. Most Common New Late Manifestations of Poliomyelitis in Patients Referred to Post-polio Clinics*

Symptom		Houston*** (n=32)	Madison**** (n=79)	Syracuse † (n=100) 1991-1993	Syracuse † (n=100) 1993-1997
Fatigue		89%	86%	83%	86%
Joint pain		71%	77%	72%	73%
Muscle pain		71%	86%	74%	73%
Weakness
	Previously affected muscles	69%	80%	88%	88%
	Previously unaffected muscles	50%	53%	61%	59%
	Total ‡	-----	87%	95%	90%
Atrophy		28%	39%	59%	52%
Cold intolerance		29%	56%	49%	53%
Respiratory insufficiency		-----	39%	42%	36%
Dysphagia		-----	30%	27%	36%
Modified from (92). Adapted from (77). All patients met the criteria for post-polio syndrome. **Adapted from (09). All patients had histories and examinations compatible with a diagnosis of previous poliomyelitis. † First 200 patients with histories and examinations compatible with diagnosis of previous poliomyelitis. ‡ Total percent of patients with new weakness.

New atrophy is not an isolated manifestation and is seen in fewer than half of the patients with new weakness (37; 77). In addition to the weakness and atrophy caused by the disintegration of the lower motor neuron unit, rarely upper motor neuron signs can occur (90). They include hyperreflexia, Babinski signs, and occasionally, spasticity. Of 180 post-polio syndrome patients, upper motor neuron signs were found in 15 (8.3%) (90), which is similar to the frequency of motor neuron signs found during acute poliomyelitis (90). Muscle pain (myalgias), which occurs in most patients (41; 77; 91), appears to be due to overuse of weak muscles. Similar symptoms occur in overused weakened muscles in other neuromuscular diseases (90). The pain is a soreness or aching feeling that occurs with minimal exercise. Some patients have muscle tenderness on palpation.

New muscle weakness may also involve specific muscle groups, causing bulbar muscle weakness, respiratory insufficiency, and sleep apnea. Bulbar muscle weakness is most frequently manifested by dysphagia, which has been reported in 10% to 36% of post-polio patients (32; 158). It is primarily due to pharyngeal and laryngeal muscle weakness; however, local pharyngeal or esophageal problems should also be excluded. Patients may complain of food sticking, making swallowing slow and difficult, often with coughing and choking (32). Videofluoroscopic studies may reveal impaired tongue movements, delayed pharyngeal constriction, pooling in the valleculae or pyriform sinuses, and rarely aspiration, which is usually mild (158). Less frequently, other bulbar muscles, such as the facial muscles and vocal cords, may become weaker in post-polio syndrome (34; 01); dysarthria has also been reported (90).

Respiratory insufficiency primarily occurs in patients with severe residual respiratory impairment and minimal reserve from their acute polio illness (53; 23; 157). Similar to limb weakness, respiratory failure is more likely to occur in patients who required respiratory support during the acute disease and, hence, had more severe disease and in those who contracted polio at an age of 10 years or older (53; 157). Patients with post-polio syndrome chronic respiratory failure lose an average of 1.9% of their vital capacity per year (16). It is usually due to respiratory muscle weakness but can also be due to central hypoventilation because of the residual damage from acute bulbar poliomyelitis (137). Other factors, such as cardiac or pulmonary disease or scoliosis, may contribute to the problem. Initially, respiratory failure begins with nocturnal hypoventilation, and patients may require only nighttime respiratory support (82). If already on nighttime respiratory support, patients may eventually require total ventilator support (16).

Sleep apnea is not an uncommon problem in post-polio patients. It may be central, obstructive, or mixed (73; 163). Most patients with central sleep apnea had bulbar polio, and some required ventilatory support (73; 154). Probably residual damage to the brainstem reticular formation predisposes to central sleep apnea. Obstructive sleep apnea appears to be related to pharyngeal muscle weakness, obesity, and musculoskeletal deformities (163). Respiratory muscle weakness may also contribute to sleep apnea (15). Fasciculation and cramps without weakness, muscle pseudohypertrophy, and tingling paresthesia are other neuromuscular problems that occur infrequently in post-polio patients, with or without new weakness (90).

Musculoskeletal manifestations. Pain from joint instability is the major musculoskeletal problem and can occur without new weakness. The long-term overstress of joints because of residual weakness eventually results in joint deterioration and pain (98; 169). Progressive scoliosis, poor posture, unusual mechanics because of weak muscles, uneven limb size, bone deformities, overstressed tendons, failing tendon transfers, and failing joint fusions can all contribute to joint instability, increased fracture risk, and pain. These joint problems frequently lead to loss of mobility and a return to using old assistive devices (12). Progressive scoliosis may also contribute to pulmonary failure (112). Compressive radiculopathies and mononeuropathies may occur as secondary musculoskeletal complications (90; 175).

Systemic manifestations. Fatigue is the most prominent systemic manifestation, occurring in up to 80% of patients (51; 77; 90; 09). It is generally described as a disabling generalized exhaustion that follows even minimal physical activity (79). Patients frequently refer to hitting the “polio wall.” Their fatigue has also been described as “increasing physical weakness,” “tiredness,” “lack of energy,” and “increasing loss of strength during exercise” (20); thus, it can either be perceived as generalized or muscular in origin (79; 05). Fatigue can also affect mental as well as physical functioning. It may be improved by decreasing physical activity, pacing daily activities, and taking frequent rest periods and naps (05; 129). Post-polio syndrome fatigue appears to respond better to sleep than that of chronic fatigue syndrome, although frequent rest periods are also helpful. Apathy and decreased verbal fluency are also seen in a high proportion of patients. However, extensive cerebral neuroimaging studies of 36 post-polio patients with cognitive symptoms only demonstrated minimal cortical, subcortical, and white matter degeneration (153). In their study of fatigued and non-fatigued patients with post-polio syndrome, Östlund and colleagues report that fatigued post-polio patients can be considered a distinct subgroup across the fatigue continuum (128).

Other systemic manifestations less frequently reported include increased sleep requirements, cold intolerance, and psychological stresses (77; 90). Increased sleep requirements probably relate to severe fatigue. Many post-polio syndrome patients complain of cold intolerance (77). They report worsening symptoms, including increasing generalized fatigue and weakness when exposed to cold temperatures (31). Patients may also develop coolness and color changes, such as cyanosis and blanching of the affected extremity that probably relate to sympathetic intermediolateral column damage from the acute poliomyelitis (156). Psychological symptoms appear to relate to the re-emergence of a supposedly old resolved problem and to the stresses of new disabilities and the accompanying major lifestyle changes (101; 29; 33).

De Grandis and colleagues report a patient who developed restless legs syndrome concurrent with the development of classic post-polio syndrome 40 years after recovery from an episode of paralytic poliomyelitis (54). Marin and colleagues report a high prevalence of restless legs syndrome (36%) amongst 119 post-polio patients seen consecutively in their outpatient neuromuscular clinic (113).

Prognosis and complications

It has been difficult to determine the natural course of post-polio syndrome because of its slow progression with plateaus. However, weakness does lend itself to objective analysis. Mulder and colleagues (120) reported continuous progression of weakness over 12 years of follow-up. Dalakas and colleagues (49) used Medical Research Council grading and noted both steady and stepwise progression of weakness at an average rate of only 1% per year over a mean follow-up period of 12.2 years. Some studies with shorter follow-up periods of two years (86), two and a half years (10), and five years (183) did not demonstrate progression of the weakness. However, the latter group did demonstrate progression when patients were followed for a much longer period of 15 years (159). Two mechanically quantitated studies, with four-year follow-up periods, found rates of progression of 2% per year (03; 161). A quantitative study of only nine months duration found that the annual percentage decrease in strength varied from 11.2% for polio survivors in their early 40s to 17.5% for those in their late 60s and early 70s (99). Significant objective clinical weakening has been noted by others (121), including weakness of bulbar musculature (158). The prognosis is good when diaphragmatic paralysis is unilateral. It often goes unrecognized and, in the absence of any underlying lung disease, usually needs no treatment. Bilateral diaphragmatic paralysis can cause dyspnea, cor pulmonale, and ventilatory failure. Pulmonary function tests show a restrictive process, with symptoms worse on supine posture. In addition to chest x-ray, chest fluoroscopy, phrenic nerve conduction studies, and diaphragmatic electromyography help to confirm the diagnosis. Diaphragmatic pacing, placation of the diaphragm, tracheostomy, and mechanical ventilation might be needed alone or in combination (139).

Additional complications of post-polio syndrome most often relate to spine disease. Arthritis (spondylosis) of the spine and herniated discs may result in radiculopathies. These complications respond somewhat to conservative treatment and more often to surgical intervention, although this may be short-lived. Kyphoscoliosis may occur, which may result in respiratory and cardiac failure (112). At this stage, treatment is primarily supportive. Bulbar muscle weakness may predispose to aspiration and pneumonia.

Biological basis

Etiology and pathogenesis

It is now recognized that normal aging alone cannot explain the development of post-polio syndrome because the normal loss of anterior horn cells and motor units does not become prominent until after age 60 (90). More important than a patient’s chronological age is the interval from their acute polio to the onset of post-polio syndrome, an interval that averages between 30 and 40 years (90). The presently accepted most likely etiologic possibility is degeneration of enlarged motor units; however, alternative considerations include a chronic persistent poliovirus infection or an immune-mediated disease (18).

Degeneration of enlarged motor units. After acute poliomyelitis, remaining motor neurons send out sprouts to take over degenerated muscle fibers (collateral sprouting). This results in enlarged motor units, five to 10 times larger than normal. These new synapses never seem to stabilize fully (177). On average, 30 to 40 years after acute poliomyelitis, there is disintegration of the new terminal sprouts that formed after the acute infection (47; 71). Findings from single fiber electromyographic (SFEMG) studies reveal that the largest motor units are more likely to become unstable later in life (36; 59), and with increasing time from the acute polio, neuromuscular transmission becomes more unstable, as increased jitter and blocking occur (178). Spontaneous denervation activity, jitter, and blocking occur more frequently in symptomatic muscles (144; 114). These findings are supported by muscle biopsy studies that describe an increasing number of angulated fibers accumulating over time (50). This is followed by degeneration of axonal branches as demonstrated by the appearance of small group atrophy (57; 36). This can be followed by large group atrophy, suggesting neuronal degeneration (50). It has been frequently hypothesized that the increased metabolic demand of an increased motor unit territory results in premature exhaustion and death of the motor neuron (90). Although no definitive studies have examined the cell soma to prove this theory, electrophysiologic and muscle biopsy data appear to be supportive. The overuse of weakened muscles results in excessive muscular fatigue (152; 72; 08; 164; 165), which appears to contribute to the excessive metabolic demand on motor neurons and the premature exhaustion.

Chronic persistent poliovirus infection. Poliovirus and other picornaviruses can persist in the CNS of animals and cause delayed or chronic disease (90; 55; 18). Poliovirus and other enteroviruses can also persist in the CNS and systemically in immunodeficient children (90). Studies in tissue culture have found that poliovirus mutants can persist without killing the host cell (43; 26) and can also persist in neurons (132). Support for the persistent poliovirus hypothesis was enhanced by the findings of Sharief and colleagues (151), who demonstrated poliovirus antibodies and poliovirus-sensitized cells in the CSF of post-polio patients. Leon-Monzon and Dalakas (109) found elevated IgG poliovirus antibodies in the sera of post-polio syndrome patients as compared to controls; however, patients with amyotrophic lateral sclerosis had similar elevated levels. Other investigators have been unable to find poliovirus antibodies in the CSF of post-polio patients (106; 49; 146; 115; 93). CSF specimens have also been examined for the presence of poliovirus RNA by polymerase chain reaction, and the majority of studies have been negative or inconclusive (115; 109; 111; 119). The most positive study was that of Julien and colleagues (94) who detected poliovirus genome sequences in the CSF of 11 of 20 post-polio syndrome patients but in none of the 20 control patients. These same authors had reported similar findings: post-polio syndrome 5 of 10 positive, controls 0 of 23 positive, in an earlier study (111). Conclusive viral isolation and histochemical or hybridization studies have not as yet been reported using spinal cord tissues and will be required to resolve this possibility.

An immune-mediated disease. The strongest support for an inflammatory or immune-mediated mechanism for post-polio syndrome stems from the study of Pezeshkpour and Dalakas (Pezeshkpour and 47) in which inflammation in the spinal cords of seven post-polio patients was found. It consisted of both perivascular and parenchymal lymphocytic infiltrates, neuronal degeneration, and active gliosis. All changes were more prominent in three patients with new weakness. Other findings that support this hypothesis are the finding oligoclonal bands in the CSF (49) and activated T-cells in the peripheral blood (65). Others have not found oligoclonal bands in post-polio syndrome patients (36; 146); however, other histologic studies suggest an immune-mediated or viral-induced pathogenesis or at least an inflammatory mechanism. Miller (116) examined the spinal cord from one post-polio patient and found perivascular intraparenchymal chronic inflammatory infiltrates primarily composed of B lymphocytes with rare macrophages and no T-cells. Kaminski and colleagues (95) found inflammation in the spinal cords of eight of nine post-polio syndrome patients. Studies support an immune-mediated process with the finding of inflammatory cytokines (TNF-alpha, IFN-gamma, IL-4, IL-10) in the CSF of post-polio syndrome patients (67; 68).

In a study of patients with post-polio syndrome, Bickerstaffe and colleagues measured plasma TNF-α, IL-6, IL-8, and leptin levels and found them to be significantly increased compared to healthy controls (22). However, they found no association between these raised systemic levels of inflammatory mediators and long-term decline in quadriceps strength or other clinical parameters. In conclusion, this study suggests that there is evidence for systemic inflammation in post-polio syndrome, yet the relationship with clinical deterioration remains uncertain.

Prevention

Several risk factors have been identified that predispose to the development of post-polio syndrome. One is the severity of the polio and resulting paralysis (79; 04; 184; 166). The more severe the disease the more likely a patient will develop post-polio syndrome. Presumably, this is due to fewer motor neurons, which will result in earlier weakness when these few remaining motor neurons with enlarged motor units degenerate. The age at onset of the poliomyelitis is also a risk factor. Acute poliomyelitis in adolescents and adults is more severe than in infants and small children (90), and the former patients are more likely to develop post-polio syndrome (79; 100). Thus, older age at the time of the acute poliomyelitis as a risk factor probably relates to the greater severity of the disease. In one study, another risk factor is the amount of recovery; the greater the recovery, the more likely post-polio syndrome will occur (100), suggesting that reinnervation is unable to be maintained 30 to 40 years later. In these patients who do recover totally or partially, excessive exercise or overuse appears to predispose them to post-polio syndrome (100; 166). The only one of these risk factors that can be addressed preventively is the overuse of muscles (excessive exercise). Patients need to be educated not to excessively exercise and to pace their activities. Post-polio syndrome patients should not allow themselves to have muscle fatigue (increased weakness, loss of muscle tone, muscle numbness, muscle soreness) or even excessive generalized fatigue after exercise. Their exercise must be paced and be non-fatiguing.

In their descriptive study, Winberg and colleagues found that despite a progressive physical disability, people with late effects of polio are physically active, but much of it is performed as part of their household activities and not as traditional exercise (181). The relationship between physical activity, life satisfaction, and age further supports the general contention that an active lifestyle is an important factor for perceived well-being among older people. In ambulatory persons with late effects of polio, knee muscle strength and gait performance explain only a small portion of physical activity, necessitating further studies to understand how other impairments, activity limitations, environmental factors, and personal factors influence physical activity in persons with late effects of polio (182).

Differential diagnosis

Confusing conditions

Because the neurologic manifestations of post-polio syndrome are primarily those of a lower motor neuron or motor axonopathy, the differential diagnosis primarily encompasses diseases manifesting lower motor neuron or peripheral nerve involvement. These diseases are adult-onset spinal muscular atrophy (80; 123), multifocal motor neuropathy (168), chronic inflammatory polyradiculopathy (27), plasma cell dyscrasias (107), motor neuropathy and monoclonal gammopathy (28), hexosaminidase deficiency (88), thyrotoxicosis (142), parathyroid disorders (130), and heavy metal toxicity (44). Other entities in the differential might include lumbar spinal stenosis (75; 126), chronic disc degeneration and lumbar spondylosis (58), cauda equina syndromes (150), and lumbar-sacral cord tumors (149). Occasionally, involvement of a single extremity or nerve may be included in the differential, eg, monomelic atrophy (56), diabetic amyotrophy (19), radiculopathies, and entrapment neuropathies (52).

For the rare post-polio patient with upper motor neuron signs, amyotrophic lateral sclerosis (143), cervical spondylosis (162), foramen magnum tumors (60), and tumors of the cervical and thoracic cord (149) are part of the differential diagnosis.

Because fatigue is such a prominent feature of the post-polio syndrome, diseases that frequently cause this complaint such as myasthenia gravis (61), myasthenic syndrome (61), and some myopathies (124) and medical diseases (cardiac, hematologic, endocrine, cancer, chronic systemic infections) must be excluded. A number of unusual entities, manifested primarily by muscle pain, cramps, and fasciculations (85; 42; 13) also should be excluded. A syndrome of acute asymmetric flaccid paralysis has been described in numerous patients with West Nile virus infection (108). This resembles the paralysis of the anterior horn cell poliomyelitis seen in polio victims and is often associated with disabling fatigue and frequently hinders rehabilitation efforts.

Associated or underlying disorders

Sleep apnea--either central, obstructive, or mixed--is associated (73; 163).

Osteopenia and osteoporosis are also associated, predisposing to increased fracture risk (118).

Diagnostic workup

Because generalized fatigue is one of the most frequent manifestations of post-polio syndrome, many systemic diseases must be excluded. Most of these diseases can usually be excluded with blood tests and include hypo- and hyperthyroidism, anemia, leukemia, and cancer, which cause an elevated erythrocyte sedimentation rate and other blood test abnormalities, liver failure, and kidney failure. Cardiac failure and sleep disorders also need to be excluded as causes of fatigue. In post-polio syndrome patients, the creatinine kinase is often mildly elevated (90; 122; 184; 172). In one study, elevated creatinine kinase levels were more likely to occur in those with progressive weakness (184), and markedly increased levels indicated muscle overuse (134). Electrodiagnostic studies cannot differentiate patients with post-polio syndrome from asymptomatic post-polio patients (36; 92). However, these studies are important to exclude other neuromuscular diseases (amyotrophic lateral sclerosis, radiculopathy, polyneuropathy, myasthenia gravis, and myopathies). In a comparative EMG analysis of muscle activity and assessment of muscle strength and fatigue after maximal isometric contraction during knee extension in post-polio patients, Correa and colleagues were able to show a decreased endurance on initial muscle contraction and during contraction 15 minutes after the initial maximal voluntary contraction, along with muscle fatigue that was assessed through linear regression (46). Imaging studies (eg, CT, MRI) are needed to exclude spine problems such as spondylosis and stenosis.

Hachisuka and colleagues studied 43 polio survivors and 20 healthy controls with motor nerve conduction studies of the median and tibial nerves bilaterally, including sampling of F-waves elicited by 100 stimuli and the determination of motor unit number estimation (MUNE), with the intent to determine whether F-waves reveal electrophysiological features of anterior horn cells in polio survivors (74). They found a significant increase in abnormally stereotyped ("repeater") F-waves and a reduction of F-wave persistence in both nerves in the polio group compared to the control group. Repeater F-waves had a negative correlation with MUNE. It is well known that repeater F-waves are signs of motor unit pathology. The authors conclude that the trends in F-wave persistence and repeater F-waves following motor unit loss are characteristic findings in polio survivors.

Gonzalez and colleagues report that the CSF of persons with post-polio syndrome displayed a disease-specific and highly predictive (p=0.0017) differential expression of five distinct proteins: gelsolin, hemopexin, peptidylglycine alpha-amidating monooxygenase, glutathione synthetase, and kallikrein 6 in comparison with the control groups (70). An independent ELISA confirmed the increase of kallikrein 6, suggesting that these five proteins should be further evaluated as candidate biomarkers for the diagnosis and development of new therapies for post-polio syndrome patients.

Management

Generalized fatigue is best treated with lifestyle changes consisting of energy conservation measures (frequent rest periods and daytime naps, pacing of physical activities), weight-loss programs, avoidance of sedating medications, treatment of sleep or respiratory disorders, and the use of assistive devices (orthoses, canes, intermittent use of wheelchairs) (171; 133). Sleep disorder screening should also be considered as even an unrelated sleep disorder could exacerbate post-polio symptoms (110). Pharmacological agents (amantadine, pyridostigmine, fluoxetine, methylphenidate, modafinil, and coenzyme Q10) may be postulated to have a role in the amelioration of generalized fatigue. However, agents, including amantadine, pyridostigmine, modafinil, and coenzyme Q10, have been studied in a controlled fashion in post-polio fatigue, and all four were found to lack benefit (48; 167; 40; 135).

The most important advance in the treatment of new post-polio syndrome weakness is the finding in at least nine studies that mild-to-moderate weakness can be improved with a non-fatiguing exercise program (62; 07; 92; 39). All of these studies demonstrated increased muscle strength, and none showed laboratory evidence of muscle overuse (eg, an increase in creatinine kinase or electromyographic or biopsy evidence of muscle damage). These non-fatiguing exercise programs avoid overuse by using both submaximal and maximal strength combined with short-duration repetitions. Exercise should be performed on alternate days to allow for full recovery and to avoid overuse. A physical therapist is often needed to instruct patients on appropriate exercise techniques and to monitor the patients so they do not overexert. Patients with post-polio syndrome who could exercise at a level that avoided overuse (excessive muscle fatigue or increasing muscle or joint pain) have experienced positive results (06). Muscle fatigue can also be improved by interspersing bouts of activity with rest periods (pacing) to avoid excessive fatigue (05). This simple procedure significantly improved strength recovery after activity (05). Patients with post-polio syndrome who exert their weak muscles to the point of exhaustion (overuse) may require two to three days to recover from the resulting muscle fatigue. Furthermore, high intensity exercise regiments were not well tolerated and did not result in improved muscle strength or cardiovascular fitness (170). Pharmacological intervention with pyridostigmine and prednisone did not improve long-term muscle strength (48; 167). A clinical trial to understand the potential role of treatment with L-citrulline has been completed, but results are unpublished (148).

Koopman and colleagues conducted a multicenter, single-blinded, randomized controlled trial to study the efficacy of exercise therapy and cognitive therapy on reducing fatigue and improving activities and health-related quality of life in patients with post-polio syndrome (103). Over four months, severely fatigued patients with post-polio syndrome received exercise therapy, cognitive therapy, or usual care. Of 68 randomized patients, no differences were observed between the intervention and usual care groups for fatigue, suggesting that neither exercise therapy nor cognitive therapy was superior to usual care in reducing fatigue in severely fatigued post-polio syndrome patients.

In their report of an EFNS task force on post-polio syndrome, Farbu and colleagues recommend Halstead's definition of post-polio syndrome from 1991 as diagnostic criteria (63). They feel supervised, aerobic muscular training, both isokinetic and isometric, is a safe and effective way to prevent further decline for patients with moderate weakness (Level B). Muscular training can also improve muscular fatigue, muscle weakness, and pain. Farbu and colleagues note that training in a warm climate and non-swimming water exercises are particularly useful (Level B). They further add that recognition of respiratory impairment and early introduction of noninvasive ventilatory aids prevent or delay further respiratory decline and the need for invasive respiratory aid (Level C).

Bulbar muscle weakness may also lead to dysphagia, respiratory failure, and sleep disorders. Dysphagia can be improved by instruction on swallowing techniques (155). Chronic respiratory failure can often be managed with nighttime noninvasive positive-pressure ventilation (14). Mouth and nasal intermittent positive pressure ventilation, manually and mechanically assisted coughing, and noninvasive blood gas monitoring in the home were the main techniques used for optimizing quality of life and for avoiding complications (17). With the use of these measures, acute respiratory failure and tracheal intubation can usually be avoided (14). Only a small percentage of patients eventually require tracheotomy and permanent ventilation. Although not evidenced-based, influenza and pneumococcal vaccines are probably indicated. Smoking should be eliminated and obstructive disease treated. Sleep disorders occur frequently in post-polio syndrome patients and are treated similarly to sleep apnea seen in patients without post-polio syndrome (92). In patients with post-polio syndrome, Hsu and Staats identified three patterns of sleep disturbances: (1) obstructive sleep apnea, (2) hypoventilation, and (3) a combination of both (83). They further proposed that sleep-related disordered breathing (SRDB) is a late sequela of poliomyelitis, and clinical evaluation should include information about sleep. Another study found that transcranial direct current stimulation (tDCS) over the premotor areas for 15 days improved sleep and fatigue symptoms in patients with post-polio syndrome (02). Acler and colleagues further added that tDCS could be a noninvasive and valuable new tool for managing post-polio patients.

Musculoskeletal pain (muscle and joint pain) and joint instability can be treated with braces and wheelchairs (171), pacing activities (180) and lifestyle changes (133). Anti-inflammatory medications, anti-depressant pain medications (eg, amitriptyline, duloxetine), heat, and massage appear to be somewhat beneficial but have not been studied objectively. In a small, randomized controlled trial, lamotrigine significantly improved pain, muscle cramps, and fatigue at two and four weeks (125).

Osteopenia and osteoporosis are increasingly associated with post-polio syndrome, predisposing to increased fracture risk (118). Thus, bone density assessment, review of fall risk, and preventative intervention should be considered for all patients. Additionally, these patients are at high risk for intraoperative skeletal complications, and additional surgical planning for bone fracture repair is important (117).

Cardiac conditioning is important for all patients, and three trials using aerobic or general conditioning exercise with lower-limb cycle or arm ergometers have shown significant improvement in cardiorespiratory fitness in post-polio syndrome patients (104; 62; 06). Two aquatic exercise studies have demonstrated that flexibility, strength, and cardiorespiratory fitness can be improved in post-polio syndrome patients (138; 179). Finally, it is important to note that psychological symptoms related to the re-emergence of a supposedly resolved disease and the stresses of the needed major lifestyle changes can sometimes be overwhelming (92; 96).

The inflammatory or immune-mediated hypotheses, best supported by the increased expression of inflammatory cytokines in cerebrospinal fluid (CSF), has resulted in many clinical trials in post-polio syndrome, including prednisone and intravenous immunoglobulin (IVIG). Prednisone did not improve long-term muscle strength or fatigue (167). There have been many studies with IVIG. Randomized control studies have shown that IVIG is effective in reducing pain in complex regional pain syndrome (low-dose IVIG) and post-polio syndrome (high-dose IVIG) (66). Open trials have also shown efficacy in additional pain conditions. Farbu and colleagues, in their small pilot study on post-polio syndrome patients, concluded that no effect was seen with IVIG treatment on muscle strength and fatigue; however, IVIG-treated post-polio syndrome patients reported significantly less pain three months after treatment (64). TNF-alpha was increased in the CSF of post-polio syndrome patients. Ostlund and associates reported that IVIG leads to an increase of quality of life at 6-month follow-up by improving vitality, social function, and role-emotional, with significant decrease in bodily pain (127). Gonzalez and colleagues have also reported that IVIG therapy has sustained positive effects on relevant QoL variables and reduction of inflammatory cytokines for up to 1 year in patients with post-polio syndrome (69). However, systematic reviews and meta-analysis highlight the inconsistencies with IVIG treatment in post-polio syndrome, and the clinical use of IVIG cannot yet be recommended (84; 102).

Table 2. Evidence-Based Treatment for Patients with Post-polio Syndrome*†

Generalized fatigue
	• Institute lifestyle changes, including energy conservation, mood disorder management, sleep disorder screening, and weight-loss programs • Prescribe appropriate lower extremity orthoses
Muscle weakness and fatigue
	• Institute a non-fatiguing strengthening exercise program (mild-to-moderate weakness) • Institute physical activity pacing with rest periods • Prescribe appropriate assistive devices • Avoid overuse of weakened muscles
Bulbar muscle weakness
	• Dysphagia
		- Instruction on swallowing techniques
	• Respiratory failure
		- Noninvasive positive-pressure ventilation at night and as needed - Tracheostomy and permanent ventilation
Musculoskeletal pain, joint instability, and bone health
	Decrease mechanical stress on joints and muscles
		- Lifestyle changes such as weight loss, pacing activities - Using assistive devices (including orthoses, wheelchairs, and adaptive equipment) - Bone density and fall risk assessment and intervention
	• Prescribe anti-inflammatory medications, anti-depressant pain medications, lamotrigine, heat, and massage
Cardiopulmonary conditioning
	• Cycle or arm ergometer exercise • Exercise training under supervision of physical therapist
*All of the interventions are evidence-based except for tracheostomy and permanent ventilation; and prescribing anti-inflammatory medications, anti-depressant pain medications, heat and massage. †Adapted from (89). See text for references.

References

01: Abaza MM, Sataloff RT, Hawkshaw MJ, Mandel S. Laryngeal manifestations of postpoliomyelitis syndrome. J Voice 2001;15(2):291-4. PMID 11411483
02: Acler M, Bocci T, Valenti D, Turri M, Priori A, Bertolasi L. Transcranial Direct Current Stimulation (tDCS) for sleep disturbances and fatigue in patients with post-polio syndrome. Restor Neurol Neurosci 2013;31(5):661-8. PMID 23863351
03: Agre JC, Grimby G, Rodriquez AA, Einarsson G, Swiggum ER, Franke TM. A comparison of symptoms between Swedish and American post-polio individuals and assessment of lower limb strength--a four-year cohort study. Scand J Rehabil Med 1995;27(3):183-92. PMID 8602481
04: Agre JC, Rodriquez AA. Neuromuscular function: comparison of symptomatic and asymptomatic polio subjects to control subjects. Arch Phys Med Rehabil 1990;71(8):545-51. PMID 2369288
05: Agre JC, Rodriquez AA. Intermittent isometric activity: its effect on muscle fatigue in postpolio subjects. Arch Phys Med Rehabil 1991;72(12):971-5. PMID 1953320
06: Agre JC, Rodriquez AA. Muscular function in late polio and the role of exercise in post-polio patients. NeuroRehabiliation 1997;8(2):107-18. PMID 24525981
07: Agre JC, Rodriquez AA, Franke TM. Strength, endurance, and work capacity after muscle strengthening exercise in postpolio subjects. Arch Phys Med Rehabil 1997;78(7):681-6. PMID 9228868
08: Agre JC, Rodriquez AA, Franke TM. Subjective recovery time after exhausting muscular activity in postpolio and control subjects. Am J Phys Med Rehabil 1998;77(2):140-14. PMID 9558015
09: Agre JC, Rodriquez AA, Sperling KB. Symptoms and clinical impressions of patients seen in a postpolio clinic. Arch Phys Med Rehabil 1989;70(5):367-70. PMID 2719539
10: Allen GM, Gandevia AS, Middleton J. Quantitative assessments of elbow flexor muscle performance using twitch interpolation in post-polio patients: no evidence for deterioration. Brain 1997;120(Pt 4):663-72. PMID 9153128
11: Alter M, Kurland LT, Molgaard CA. Late progressive muscular atrophy and antecedent poliomyelitis. Adv Neurol 1982;36:303-9. PMID 6983825
12: Anderson AD, Levine SA, Gellert H. Loss of ambulatory ability in patients with old anterior poliomyelitis. Lancet 1972;2(7786):1061-3. PMID 4117381
13: Ashizawa T, Butler IJ, Harati Y, Roongta SM. A dominantly inherited syndrome with continuous motor neuron discharges. Ann Neurol 1983;13(3):285-90. PMID 6847141
14: Bach JR. Management of post-polio respiratory sequelae. Ann N Y Acad Sci 1995;753:96-102. PMID 7611664
15: Bach JR, Alba AS. Pulmonary dysfunction and sleep disordered breathing as post-polio sequelae: evaluation and management. Orthopedics 1991;14(12):1329-37. PMID 1784549
16: Bach JR, Alba AS, Bodofsky E, Curran FJ, Schulteiss M. Glossopharyngeal breathing and noninvasive aids in the management of post-polio respiratory insufficiency. Birth Defects Orig Artic Ser 1987a;23(4):99-113. PMID 3304449
17: Bach JR, Alba AS, Bohatiuk G, Saporitol L, Lee M. Mouth intermittent positive pressure ventilation in the management of postpolio respiratory insufficiency. Chest 1987b;91(6):859-64. PMID 3556055
18: Baj A, Colombo M, Headley JL, McFarlane JR, Liethof MA, Toniolo A. Post-poliomyelitis syndrome as a possible viral disease. Int J Infect Dis 2015;35:107-16. PMID 25939306
19: Barohn RJ, Sahenk Z, Warmolts JR Mendell JR. The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol 1991;48(11):1130-5. PMID 1953396
20: Berlly MH, Strauser WW, Hall KM. Fatigue in postpolio syndrome. Arch Phys Med Rehabil 1991;72(2):115-8. PMID 1991011
21: Bertolasi L, Acler M, Dall'ora E, et al. Risk factors for post-polio syndrome among an Italian population: a case-control study. Neurol Sci 2012;33(6):1271-5. PMID 22246456
22: Bickerstaffe A, Beelen A, Lutter R, Nollet F. Elevated plasma inflammatory mediators in post-polio syndrome: No association with long-term functional decline. J Neuroimmunol 2015;289:162-7. PMID 26616886
23: Blomstrand A, Bake B. Post-polio lung function. Scand J Rehab Med 1992;24(1):43-9. PMID 1604261
24: Bodian D. Poliomyelitis: pathologic anatomy. In: International Poliomyelitis Congress, editor. Poliomyelitis: papers and discussions presented at the First International Poliomyelitis Conference. Philadelphia: JB Lippincott, 1949:62-84.
25: Bodian D, Howe HA. The pathology of early averted and nonparalytic poliomyelitis. Bull Johns Hopkins Hosp 1941;69:135-47.
26: Borzakian S, Couderc T, Barbier Y, Attal G, Pelletier I, Colbere-Garapin F. Persistent poliovirus infection: establishment and maintenance involve distinct mechanisms. Virology 1992;186(2):398-408. PMID 1310176
27: Bouchard C, Lacroix C, Plante V, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 1999;52(3):498-503. PMID 10025777
28: Brannagan TH, Latov N. Motor neuropathy and monoclonal gammopathy. In: Younger DS, editor. Motor disorders. Philadelphia: Lippincott Williams & Wilkins, 1999.
29: Bruno RL. Post-polio sequelae: research and treatment in the second decade. Orthopedics 1991;14(11):1169-70. PMID 1661890
30: Bruno RL, Frick NM. The psychology of polio as prelude to post-polio sequelae: behavior modification and psychotherapy. Orthopedics 1991;14(11):1185-93. PMID 1758786
31: Bruno RL, Johnson JC, Berman WS. Motor and sensory functioning with changing ambient temperature in post-polio subjects: autonomic and electrophysiological correlates. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami: Symposia Foundation, 1985:95-108.
32: Buchholz DW, Jones B. Post-polio dysphagia: alarm or caution. Orthopedics 1991;14(12):1303-5. PMID 25630548
33: Burger H, Marincek C. The influence of post-polio syndrome on independence and life satisfaction. Disabil Rehabil 2000;22(7):318-22. PMID 10877485
34: Cannon S, Ritter FN. Vocal cord paralysis in postpoliomyelitis syndrome. Laryngoscope 1987;97(8 Pt 1):981-3. PMID 3613801
35: Carriere. Amyotrophies Secondair. These de Montpelier, reviewed by Potts, 1903. See reference 133. 1875.
36: Cashman NR, Maselli R, Wollman RL, Roos R, Simon R, Antel JP. Late denervation in patients with antecedent paralytic poliomyelitis. N Engl J Med 1987a;317(1):7-12. PMID 3587319
37: Cashman NR, Maselli R, Wollmann R, Simon R, Heidkamp P, Antel JP. New muscle atrophy as a late symptom of the post-poliomyelitis syndrome. Clin Ecol 1987b;5:11-3.
38: Centers for Disease Control: Poliomyelitis Surveillance Summary 1979. Centers for Disease Control, Atlanta, April 1981.
39: Chan KM, Amirjani N, Sumrain M, Clarke A, Strohschein FJ. Randomized controlled trial of strength training in post-polio patients. Muscle Nerve 2003;27(3):332-8. PMID 12635120
40: Chan KM, Strohschein FJ, Rydz D, Allidina A, Shuaib A, Westbury CF. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients. Muscle Nerve 2006;33:138-41. PMID 16175627
41: Codd MB, Mulder DW, Kurland LT, Beard CM, O’Fallon WM. Poliomyelitis in Rochester, Minnesota, 1935-1955: epidemiology and long-term sequelae. A preliminary report. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami: Symposia Foundation, 1985:121-34.
42: Coers C, Telerman-Toppet N, Durdu J. Neurogenic benign fasciculations, pseudomyotonia, and pseudotetany. A disease in search of a name. Arch Neurol 1981;38(5):282-7. PMID 7224912
43: Colbere-Garapin F, Christodoulou C, Crainic R, Pelletier I. Persistent poliovirus infection of human neuroblastoma cells. Proc Natl Acad Sci U S A 1989;86(19):7590-4. PMID 2552448
44: Conradi S, Ronnevi LO, Norris FH. Motor neuron disease and toxic metals. Adv Neurol 1982;36:201-31. PMID 6817611
45: Cornil, Lepine. Sur un cas de paralysic generale spinale anterieure subaigue, suivi d’autopsie. Gaz Med (Paris) 1875;4:127.
46: Correa JC, Rocco CC, de Andrade DV, Peres JA, Correa FI. Electromyographic and neuromuscular analysis in patients with post-polio syndrome. Electromyogr Clin Neurophysiol 2008;48(8):329-33. PMID 19097472
47: Dalakas MC. Morphologic changes in the muscles of patients with post-poliomyelitis neuromuscular symptoms. Neurology 1988;38(1):99-104. PMID 3336469
48: Dalakas MC. Why drugs fail in post-polio syndrome: lessons from another clinical trial. Neurology 1999;53(6):1166-7. PMID 10522866
49: Dalakas MC, Elder G, Hallett M, et al. A long-term follow-up study of patients with post-poliomyelitis neuromuscular symptoms. N Engl J Med 1986;314(15):959-63. PMID 3007983
50: Dalakas MC, Illa I. Post-polio syndrome: concepts in clinical diagnosis, pathogenesis, and etiology. Adv Neurol 1991;56:495-511. PMID 1853779
51: Dalakas MC, Sever JL, Madden KL, et al. Late postpoliomyelitis muscular atrophy: clinical, virologic, and immunologic studies. Rev Infect Dis 1984;6 Suppl 2:S562-7. PMID 6330854
52: Dawson DM, Hallett M, Millender LH. Entrapment neuropathies 3rd ed. Boston: Little, Brown and Company, 1999.
53: Dean E, Ross J, Road JD, Courtenay L, Madill KJ. Pulmonary function in individuals with a history of poliomyelitis. Chest 1991;100(1):118-23. PMID 2060329
54: De Grandis E, Mir P, Edwards MJ, Bhatia KP. Restless legs may be associated with the post-polio syndrome. Parkinsonism Relat Disord 2009;15(1):74-5. PMID 18374619
55: Destombes J, Couderc T, Thiesson D, Girard S, Wilt SG, Blondel B. Persistent poliovirus infection in mouse motoneurons. J Virol 1997;71(2):1621-8. PMID 8995689
56: Donofrio PD. AAEM case report #28: monomelic amyotrophy. Muscle Nerve 1994;17(10):1129-34. PMID 7935519
57: Drachman DB, Murphy SR, Nigam MP, Hills JR. “Myopathic” changes in chronically denervated muscle. Arch Neurol 1967;16(1):14-24. PMID 6024250
58: Ehni G. Effects of certain degenerative diseases of the spine, especially spondylosis and disk protrusion, on the neural contents, particularly in the lumbar region. Historical account. Mayo Clin Proc 1975;50(6):327-38. PMID 1092927
59: Emeryk B, Rowinska-Marcinska K, Ryniewicz B, Hausmanowa-Petrusewicz I. Disintegration of the motor unit in post-polio syndrome. Part II. Electrophysiological findings in patients with post-polio syndrome. Electromyogr Clin Neurophysiol 1990;30(8):451-8. PMID 2286169
60: Endtz LJ, Fresay JJ. Studies on astereognosis and amyotrophy of the hand in brainstem syndromes. Relation to the symptomatology of tumours at the spinocranial junction. J Neurol Sci 1980;44(2-3):241-6. PMID 7354369
61: Engel AG. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press, 1999.
62: Ernstoff B, Wetterqvist H, Kvist H, Grimby G. Endurance training effect on individuals with postpoliomyelitis. Arch Phys Med Rehabil 1996;77(9):843-8. PMID 8822672
63: Farbu E, Gilhus NE, Barnes MP, et al. EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006;13(8):795-801. PMID 16879288
64: Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 2007;14(1):60-5. PMID 17222115
65: Ginsberg AH, Gale MJ Jr, Rose LM, Clark EA. T-cell alterations in late poliomyelitis. Arch Neurol 1989;46(5):497-501. PMID 2785378
66: Goebel A. Immunoglobulin responsive chronic pain. J Clin Immunol 2010;30 Suppl 1:S103-8. PMID 20424897
67: Gonzalez H, Khademi M, Andersson M, Wallstrom E, Borg K, Olsson T. Prior poliomyelitis-evidence of cytokine production in the central nervous system. J Neurol Sci 2002;205(1):9-13. PMID 12409177
68: Gonzalez H, Khademi M, Andersson M, Wallstrom E, Borg K, Olsson T. Prior poliomyelitis IVIg treatment reduces proinflammatory cytokine production. J Neuroimmunol 2004;150:139-44. PMID 15081258
69: Gonzalez H, Khademi M, Borg K, Olsson T. Intravenous immunoglobulin treatment of the post-polio syndrome: sustained effects on quality of life variables and cytokine expression after one year follow up. J Neuroinflammation 2012;9:167. PMID 22776106
70: Gonzalez H, Ottervald J, Nilsson KC, et al. Identification of novel candidate protein biomarkers for the post-polio syndrome: implications for diagnosis, neurodegeneration and neuroinflammation. J Proteomics 2009;71(6):670-81. PMID 19100873
71: Gordon T, Hegedus J, Tam SL. Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurol Res 2004;26:174-85. PMID 15072637
72: Grimby L, Tollback A, Muller U, Larsson L. Fatigue of chronically overused motor units in prior polio patients. Muscle Nerve 1996;19:728-37. PMID 8609923
73: Guilleminault C, Motta J. Sleep apnea syndrome as a long-term sequela of poliomyelitis. In: Guilleminault C, editor. Sleep apnea syndromes. New York: Alan R Liss, 1978:309-15.
74: Hachisuka A, Komori T, Abe T, Hachisuka K. Repeater F-waves are signs of motor unit pathology in polio survivors. Muscle Nerve 2015;51(5):680-5. PMID 25154598
75: Hall S, Bartleson JD, Onofrio BM, Baker HL, Okazaki H, O’Duffy JD. Lumbar spinal stenosis: clinical features, diagnostic procedures, and results of surgical treatment in 68 patients. Ann Intern Med 1985;103:271. PMID 3160275
76: Halstead LS. A brief history of postpolio syndrome in the United States. Arch Phys Med Rehabil 2011;92(8):1344-9. PMID 21658679
77: Halstead LS, Rossi D. Post-polio syndrome: clinical experience with 132 consecutive outpatients. Birth Defects 1987;23:13-26. PMID 3620612
78: Halstead LS, Wiechers DO. Late effects of poliomyelitis. Miami: Symposia Foundation, 1985.
79: Halstead LS, Wiechers DO, Rossi CD. Late effects of poliomyelitis: a national survey. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami: Symposia Foundation, 1985:11-31.
80: Harding AE, Thomas PK. Hereditary distal spinal muscular atrophy. A report on 34 cases and a review of the literature. J Neurol Sci 1980;45:337-48. PMID 7365507
81: Hayward M, Seaton D. Late sequelae of paralytic poliomyelitis: a clinical and electromyographic study. J Neurol Neurosurg Psychiatry 1979;42:117-22. PMID 422959
82: Howard RS, Wiles CM, Spencer GT. The late sequelae of poliomyelitis. Q J Med 1988;66(251):219-32. PMID 3200962
83: Hsu AA, Staats BA. “Postpolio sequelae” and sleep-related disordered breathing. Mayo Clin Proc 1998;73(3):216-24. PMID 9511778
84: Huang YH, Chen HC, Huang KW, et al. Intravenous immunoglobulin for postpolio syndrome: a systematic review and meta-analysis. BMC Neurol 2015;15:39. PMID 25886512
85: Hudson AJ, Brown WF, Gilbert JJ. The muscular pain-fasciculation syndrome. Neurology 1978;28:1105-9. PMID 568728
86: Ivanyi B, Nelemans PJ, de Jonghe R, Ongerboer de Visser BW, DeVissser M. Muscle strength in post-polio patients: a prospective follow-up study. Muscle Nerve 1996;19:738-42. PMID 8609924
87: Ivanyi B, Nollet F, Redekop WK, et al. Late onset polio sequelae: Disabilities and handicaps in a population-based cohort of the 1956 poliomyelitis outbreak in The Netherlands. Arch Phys Med Rehabil 1999;80:687-90. PMID 10378496
88: Johnson WG. Hexosaminidase deficiency: a cause of recessively inherited motor neuron diseases. Adv Neurol 1982;36:159-63. PMID 6817610
89: Jubelt B, Agre JC. Characteristics and management of postpolio syndrome. JAMA 2000;284(4):412-4. PMID 10904484
90: Jubelt B, Cashman NR. Neurological manifestations of the post-polio syndrome. Crit Rev Neurobiol 1987;3:199-220. PMID 3315237
91: Jubelt B, Drucker J. Post-polio syndrome: an update. Semin Neurol 1993;13(3):283-90. PMID 8272600
92: Jubelt B, Drucker J. Poliomyelitis and the post-polio syndrome. In: Younger DS, editor. Motor disorders. Philadelphia: Lippincott Williams & Wilkins, 1999:381-95.
93: Jubelt B, Salazar-Grueso EF, Roos RP, Cashman NR. Antibody titer to poliovirus in blood and cerebrospinal of patients with post-polio syndrome. Ann N Y Acad Sci 1995;753:201-7. PMID 7611629
94: Julien J, Leparc-Goffart I, Lina B, et al. Postpolio syndrome: poliovirus persistence is involved in the pathogenesis. J Neurol 1999;246(6):472-6. PMID 10431774
95: Kaminski JH, Tresser N, Hogan RE, Martin E. Pathological analysis of spinal cords from survivors of poliomyelitis. Ann N Y Acad Sci 1995;753:390-3. PMID 7611653
96: Kemp BJ, Krause JS. Depression and life satisfaction among people ageing with post-polio and spinal cord injury. Disabil Rehabil 1999;21:241-9. PMID 10381236
97: Kidd D, Howard RS, Williams AJ, Heatley FW, Panayiotopoulos CP, Spencer GT. Late functional deterioration following paralytic poliomyelitis. QJM 1997;90(3):189-96. PMID 9093596
98: Klein MG, Whyte J, Keenan MA, Esquenazi A, Polansky M. The relation between lower extremity strength and shoulder overuse symptoms: A model based on polio survivors. Arch Phys Med Rehabil 2000a;81:789-95. PMID 10857526
99: Klein MG, Whyte J, Keenan MA, Esquenazi A, Polansky M. Changes in strength over time among polio survivors. Arch Phys Med Rehabil 2000b;81:1059-64. PMID 10943755
100: Klingman J, Chui H, Corgiat M, Perry J. Functional recovery; a major risk factor for the development of postpoliomyelitis muscular atrophy. Arch Neurol 1988;45:645-7. PMID 3369971
101: Kohl SJ. Emotional response of patients with late effects of poliomyelitis. Birth Defects 1987;23:135-42. PMID 3620613
102: Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. Treatment for postpolio syndrome. Cochrane Database Syst Rev 2015;(5):CD007818. PMID 25984923
103: Koopman FS, Voorn EL, Beelen A, et al. No reduction of severe fatigue in patients with postpolio syndrome by exercise therapy or cognitive behavioral therapy: results of an RCT. Neurorehabil Neural Repair 2016;30(5):402-10. PMID 26253175
104: Kriz JL, Jones DR, Speier JL, Canine JK, Owen RR, Serfass RC. Cardiorespiratory responses to upper extremity aerobic training by post-polio subject. Arch Phys Med Rehabil 1992;73:49-54. PMID 1729974
105: Kumakura N, Takayanagi M, Hasegawa T, Ihara K, Yano H, Kimizuka M. Self-assessed secondary difficulties among paralytic poliomyelitis and spinal cord injury survivors in Japan. Arch Phys Med Rehabil 2002;83:1245-51. PMID 12235604
106: Kurent JE, Brooks BR, Madden DL, Sever JL, Engel WK. CSF viral antibodies. Evaluation in amyotrophic lateral sclerosis and late-onset postpoliomyelitis progressive muscular atrophy. Arch Neurol 1979;36:269-73. PMID 220938
107: Latov N. Plasma cell dyscrasia and motor neuron disease. Adv Neurol 1982;36:273-8. PMID 6817612
108: Leis AA, Stokic DS, Webb RM, Slavinski SA, Fratkin J. Clinical spectrum of muscle weakness in human West Nile virus infection. Muscle Nerve 2003;28:302-8. PMID 12929189
109: Leon-Monzon ME, Dalakas MC. Detection of poliovirus antibodies and poliovirus genome in patients with the post-polio syndrome. Ann N Y Acad Sci 1995;753:208-18. PMID 7611630
110: Leotard A, Levy J, Hartley S, et al. Sleep disorders in aging polio survivors: a systematic review. Ann Phys Rehabil Med 2020;63(6):543-53. PMID 31794858
111: Leparc-Goffart I, Julien J, Fuchs F, et al. Evidence of presence of poliovirus genomic sequences in cerebrospinal fluid from patients with postpolio syndrome. J Clin Microbiol 1996;34:2023-6. PMID 8818905
112: Lin MC, Liaw MY, Chen WJ, Cheng PT, Wong AM, Chiou WK. Pulmonary function and spinal characteristics: Their relationships in persons with idiopathic and postpoliomyelitis scoliosis. Arch Phys Med Rehabil 2001;82:335-41. PMID 11245755
113: Marin LF, Carvalho LBC, Prado LBF, Oliveira ASB, Prado GF. Restless legs syndrome is highly prevalent in patients with post-polio syndrome. Sleep Med 2017;37:147-50. PMID 28899527
114: Maselli RA, Cashman NR, Wollman RL, Salazar-Grueso EF, Roos R. Neuromuscular transmission as a function of motor unit size in patients with prior poliomyelitis. Muscle Nerve 1992;15:648-55. PMID 1324424
115: Melchers W, de Visser M, Jongen P, et al. The postpolio syndrome: no evidence for poliovirus persistence. Ann Neurol 1992;32:728-32. PMID 1335224
116: Miller DC. Post-polio syndrome spinal cord pathology. Ann N Y Acad Sci 1995;753:185-93. PMID 7541970
117: Mingo-Robinet J, Alonso JA, Moreno-Barrero M, Gonzalez-Garcia L, Garcia-Virto V, Aguado HJ. Technical aspects and complications in the surgical treatment of poliomyelitis-affected lower limb fractures. Rev Esp Cir Ortop Traumatol 2018;18:300017-1. PMID 29605559
118: Mohammad AF, Khan KA, Galvin L, Hardiman O, O'Connell PG. High incidence of osteoporosis and fractures in an aging post-polio population. Eur Neurol 2009;62(6):369-74. PMID 19797901
119: Muir P, Nicholson F, Spencer GT, et al. Enterovirus infection of the central nervous system of humans: lack of association with chronic neurological disease. J Gen Virol 1996;77:1469-76. PMID 8757988
120: Mulder DW, Rosenbaum RA, Layton DD. Late progression of poliomyelitis or forme fruste amyotrophic lateral sclerosis. Mayo Clin Proc 1972;47:756-61. PMID 4635567
121: Munsat TL. Post-polio syndrome. Boston: Butterworth Heinemann, 1991.
122: Nelson KR. Creatine kinase and fibrillation potentials in patients with late sequelae of polio. Muscle Nerve 1990;13:722-5. PMID 2385258
123: Norris FH Jr. Adult progressive muscular atrophy and hereditary spinal muscular atrophy. Handb Clin Neurol 1991;59:13-34.
124: Norris FH, Denys EH, U KS. Differential diagnosis of adult motor neuron disease. In: Mulder DW, editor. The diagnosis and symptomatic therapy of amyotrophic lateral sclerosis. Boston: Houghton Mifflin, 1980:53-78.
125: On AY, Oncu J, Uludag B, Ertekin C. Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study. Neurorehabilitation 2005;20:245-51. PMID 16403993
126: Onel D, Sari H, Donmez C. Lumbar spinal stenosis: clinical/radiologic therapeutic evaluation in 145 patients: conservative treatment or surgical intervention. Spine 1993;18:291-8. PMID 25628993
127: Ostlund G, Broman L, Werhagen L, Borg K. IVIG treatment in post-polio patients: evaluation of responders. J Neurol 2012;259(12):2571-8. PMID 22592288
128: Östlund G, Wahlin Å, Sunnerhagen KS, Borg K. Post polio syndrome: fatigued patients a specific subgroup. J Rehabil Med 2011;43(1):39-45. PMID 21174052
129: Packer TL, Martins I, Krefting L, Brouwer B. Post-polio sequelae: activity and post-polio fatigue. Orthopedics 1991;14:1223-6. PMID 1758789
130: Patten BM, Engel WK. Phosphate and parathyroid disorders associated with the syndrome of amyotrophic lateral sclerosis. Adv Neurol 1982;36:181-200. PMID 7180683
131: Paul JR. A history of poliomyelitis. New Haven: Yale University Press, 1971.
132: Pavio N, Buc-Caron NH, Colbere-Garapin F. Persistent poliovirus infection of human fetal brain cells. J Virol 1996;70:6395-401. PMID 8709269
133: Peach P, Olejnik S. Effect of treatment and noncompliance on post-polio sequelae. Orthopedics 1991;14:1199-203. PMID 1758787
134: Peach PE. Overwork weakness with evidence of muscle damage in a patient with residual paralysis from polio. Arch Phys Med Rehabil 1990;71(3):248-50. PMID 2317146
135: Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W. A randomized controlled trial of coenzyme C10 for fatigue in the late-onset sequelae of poliomyelitis. Complement Ther Med 2015;23(6):789-93. PMID 26645517
136: Pezeshkpour GH, Dalakas MC. Long-term changes in the spinal cords of patients with old poliomyelitis: signs of continuous disease activity. Arch Neurol 1988;45:505-8. PMID 3358701
137: Plum F, Swanson AG. Central neurogenic hyperventilation in man. AMA Arch Neurol Psychiatry 1959;81:531-49. PMID 13636523
138: Prins JH, Hartung H, Merritt DJ, Blancq RJ, Goebert DA. Effect of aquatic exercise training in persons with poliomyelitis disability. Sports Med Training Rehabil 1994;5:29-39.
139: Qureshi A. Diaphragm paralysis. Semin Respir Crit Care Med 2009;30(3):315-20. PMID 19452391
140: Ramlow J, Alexander M, LaPorte R, Kaufmann C, Kuller L. Epidemiology of the post-polio syndrome. Am Epidemiol 1992;136:769-86. PMID 1442743
141: Raymond (with contributions by essentiele de Charcot JM). Paralysie l’enfance. Atrophic musculaire consecutive. Gaz Med (Paris) 1875;4:225.
142: Rowland LP. Diverse forms of motor neuron disease. Adv Neurol 1982;36:1-11. PMID 7180675
143: Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N Engl J Med 2001;344:1688-1700. PMID 11386269
144: Ryniewicz G, Rowinska-Marcinska K, Emeryk B, Hausmanowa-Petrusewicz I. Disintegration of the motor unit in post-polio syndrome. Part I. Electrophysiological findings in patients after poliomyelitis. Electromyogr Clin Neurophysiol 1990;30:423-7. PMID 2261887
145: Sabin AB, Ward R. Nature of non-paralytic and transitory paralytic poliomyelitis in Rhesus monkeys inoculated with human virus. J Exp Med 1941;73:757-70. PMID 19871110
146: Salazar-Grueso EF, Grimaldi LM, Roos RP, Variakojis R, Jubelt B, Cashman NR. Isoelectric focusing studies of serum and cerebrospinal fluid in patients with antecedent poliomyelitis. Ann Neurol 1989;26:709-13. PMID 2513770
147: Saraswathy R. The genetics of post-polio syndrome – much to be unraveled. Indian J Med Res 2016;144(1):9-10. PMID 27834320
148: Schmidt S, Gocheva V, Zumbrunn T, et al. Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomized, placebo-controlled, double-blind trial. Trials 2017;18:116. PMID 28274276
149: Schutta HS. Spinal tumors. In: Joynt RT, Griggs RC, editors. Clinical neurology. Hagerstown, MD: Lippincott Williams & Wilkins, 1994.
150: Shapiro S. Cauda equina syndrome secondary to lumbar disc herniation. Neurosurgery 1993;332:743-7. PMID 8492849
151: Sharief MK, Hentages R, Ciaidi M. Intrathecal immune response in patients with the post-polio syndrome. N Engl J Med 1991;325(11):749-55. PMID 1651456
152: Sharma KR, Braun-Kent J, Mynhier MA, Weiner MW, Miller RG. Excessive muscular fatigue in the postpoliomyelitis syndrome. Neurology 1994;44:642-6. PMID 8164817
153: Shing SL, Lope J, Chipika RH, Hardiman O, Bede P. Extra-motor manifestations in post-polio syndrome (PPS): fatigue, cognitive symptoms and radiological features. Neurol Sci 2021;42(11):4569-81. PMID 33635429
154: Siegel H, McCutchen C, Dalakas M, et al. Physiologic events initiating REM sleep in patients with the postpolio syndrome. Neurology 1999;52:516-22. PMID 10025780
155: Silbergleit AK, Waring WP, Sullivan MJ, Maynard FM. Evaluation, treatment, and follow-up results of post-polio patients with dysphagia. Otolaryngol Head Neck Surg 1991;104:333-8. PMID 1902934
156: Smith E, Rosenblatt P, Limauro A. The role of the sympathetic nervous system in acute poliomyelitis. J Pediatr 1949;34:1-11. PMID 18127155
157: Soliman MG, Higgins SE, El-Kabir DR, Davidson AC, Williams AJ, Howard RS. Non-invasive assessment of respiratory muscle strength in patients with previous poliomyelitis. Respir Med 2005;99:1217-22. PMID 16140221
158: Sonies BC, Dalakas MC. Progression of oral-motor and swallowing symptoms in the post-polio syndrome. Ann N Y Acad Sci 1995;753:87-95. PMID 7611663
159: Sorenson EJ, Daube JR, Windebank AJ. A 15-year follow-up of neuromuscular function in patients with prior poliomyelitis. Neurology 2005;64:1070-2. PMID 15781832
160: Speir JL, Owen RR, Knapp M, Canine JK. Occurrence of post-polio sequelae in an epidemic population. In: Halstead LS, Wiechers DO, editors. Research and clinical aspects of the late effects of poliomyelitis. White Plains, NY: March of Dimes Birth Defects Foundation, 1987:39-48.
161: Stalberg E, Grimby G. Dynamic electromyography and muscle biopsy changes in a 4-year follow-up: study of patients with a history of polio. Muscle Nerve 1995;18(7):699-707. PMID 7783759
162: Stark RJ, Kennard C, Swash M. Hand wasting in spondylotic high cord compression: an electromyographic study. Ann Neurol 1981;9:58-62. PMID 7212667
163: Steljes DG, Kryger MH, Kirk BW, Millar TW. Sleep in postpolio syndrome. Chest 1990;98:113-40. PMID 2361379
164: Sunnerhagen KS, Carlsson U, Sandberg A, Stalberg E, Hedberg M, Grimby G. Electrophysiologic evaluation of muscle fatigue development and recovery in late polio. Arch Phys Med Rehabil 2000;81:770-6. PMID 10857522
165: Thomas CK, Zijdewind I. Fatigue of muscles weakened by death of motoneurons. Muscle Nerve 2006;33:21-41. PMID 16025525
166: Trojan DA, Cashman NR, Shapiro S, Tansey CM, Esdaile JM. Predictive factors for post-poliomyelitis syndrome. Arch Phys Med Rehabil 1994;75:770-7. PMID 8024423
167: Trojan DA, Collet JP, Shapiro S, et al. A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology 1999;53:1225-33. PMID 10522877
168: Van den Berg-Vos RM, Franssen H, Wokke JH, Van es HW, Van den Berg LH. Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment. Ann Neurol 2000;48:919-26. PMID 11117549
169: Vasiliadis HM, Collet JP, Shapiro S, Venturini A, Trojan DA. Predictive factors and correlates for pain in postpoliomyelitis syndrome patients. Arch Phys Med Rehabil 2002;83:1109-15. PMID 12161832
170: Voorn EL, Koopman FS, Brehm MA, et al. Aerobic exercise training in post-polio syndrome: process evaluation of a randomized controlled Trial. PLoS ONE 2016;11(7):e0159280. PMID 27419388
171: Waring WP, Maynard F, Grady W, Grady R, Boyles C. Influence of appropriate lower extremity orthotic management on ambulation, pain and fatigue in a post-polio population. Arch Phys Med Rehabil 1989;70:371-5. PMID 2719540
172: Waring WP, McLaurin TM. Correlation of creatine kinase and gait measurement in the postpolio population. Arch Phys Med Rehabil 1992;73:37-9. PMID 1729970
173: Wekre LL, Stanghelle JK, Lobben B, Oyhaugen S. The Norwegian polio study 1994: A nation-wide survey of problems in long-standing poliomyelitis. Spinal Cord 1998;36:280-4. PMID 9589529
174: Wendebourg MJ, Weigel M, Richter L, et al. Spinal cord gray matter atrophy is associated with functional decline in post-polio syndrome. Eur J Neurol 2022;29(5):1435-45. PMID 35102676
175: Werner R, Waring W, Davidoff G. Risk factors for median mononeuropathy of the wrist in postpoliomyelitis patients. Arch Phys Med Rehabil 1989;70:464-7. PMID 2543350
176: Wiechers DO. Late effects of poliomyelitis: case reports. In: Halstead LS, Wiechers DO, editors. Late effects of poliomyelitis. Miami: Symposia Foundation, 1985:3-9.
177: Wiechers DO. New concepts of the reinnervated motor unit revealed by vaccine-associated poliomyelitis. Muscle Nerve 1988;11:356-64. PMID 3398882
178: Wiechers DO, Hubbell SL. Late changes in the motor unit after acute poliomyelitis. Muscle Nerve 1981;4:524-8. PMID 6273721
179: Willen C. Physical performance and the effects of dynamic exercise in water in individuals with late polio [thesis dissertation]. Goteborg, Sweden: Department of Rehabilitation Medicine, Institute for Community Medicine, Goteborg University, 1999.
180: Willen C, Grimby G. Pain, physical activity, and disability in individuals with late effects of polio. Arch Phys Med Rehabil 1998;79:915-9. PMID 9710162
181: Winberg C, Flansbjer UB, Carlsson G, Rimmer J, Lexell J. Physical activity in persons with late effects of polio: a descriptive study. Disabil Health J 2014;7(3):302-8. PMID 24947571
182: Winberg C, Flansbjer UB, Rimmer JH, Lexell J. Relationship between physical activity, knee muscle strength, and gait performance in persons with late effects of polio. PM R 2015;7(3):236-44. PMID 25217824
183: Windebank AJ, Litchy WJ, Daube JR, Iverson RA. Lack of progression of neurologic deficit in survivors of paralytic polio: a 50 year prospective population-based study. Neurology 1996;46:80-4. PMID 8559425
184: Windebank AJ, Litchy WJ, Daube JR, Kurland LT, Codd MB, Iverson R. Late effects of paralytic poliomyelitis in Olmsted County, Minnesota. Neurology 1991;41:501-7. PMID 2011246

Contributors

All contributors' financial relationships have been reviewed and mitigated to ensure that this and every other article is free from commercial bias.

Author

Summer B Gibson MD

Dr. Gibson of the University of Utah owns stock in Recursion Pharmaceuticals.
See Profile

Editor

John E Greenlee MD

Dr. Greenlee of the University of Utah School of Medicine has no relevant financial relationships to disclose.
See Profile

Former Authors

Burk Jubelt MD (original author), Tarakad S Ramachandran MD, and Arun Ramachandran MD

Patient Profile

Age range of presentation: 19 to 65+ years
Sex preponderance: male=female
Heredity: Heredity may be a factor: possible risk factor alleles (Saraswathy 2016)
Population groups selectively affected: patients with previous poliomyelitis
Occupation groups selectively affected: none selectively affected

ICD & OMIM codes

ICD-9: Late effects of acute poliomyelitis: 138

Acute poliomyelitis with other paralysis unspecified type of poliovirus: 045.10
ICD-10: Sequelae of poliomyelitis: B91

Acute poliomyelitis: A80
OMIM: Susceptibility to poliovirus: +173850

This is an article preview.
Start a Free Account
to access the full version.

Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660

Support: service@medlink.com

Editor: editor@medlink.com

ISSN: 2831-9125

Post-polio syndrome

Associated Disorders

Chronic fatigue syndrome
Progressive muscular atrophy
Spinal muscular atrophy

Differential Diagnosis

diseases manifesting lower motor neuron involvement
diseases manifesting upper motor neuron involvement
adult-onset spinal muscular atrophy
multifocal motor neuropathy
chronic inflammatory polyradiculopathy
- plasma cell dyscrasias
- motor neuropathy
- monoclonal gammopathy
- hexosaminidase deficiency
- thyrotoxicosis
- parathyroid disorders
- heavy metal toxicity
- lumbar spinal stenosis
- chronic disc degeneration
- lumbar spondylosis
- cauda-equina syndromes
- lumbar-sacral cord tumors
- monomelic atrophy
- diabetic amyotrophy
- radiculopathies
- entrapment neuropathies
- amyotrophic lateral sclerosis
- cervical spondylosis
- foramen magnum tumors
- tumors of cervical and thoracic cord
- myasthenia gravis
- myasthenic syndrome
- some myopathies
- cardiac diseases
- hematologic diseases
- endocrine diseases
- cancer
- chronic system infections
- entities manifested by muscle pain, cramps, or fasciculations
- West Nile virus

Post-polio syndrome …

Post-polio syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. Most Common New Late Manifestations of Poliomyelitis in Patients Referred to Post-polio Clinics*

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Table 2. Evidence-Based Treatment for Patients with Post-polio Syndrome*†

Special considerations

Anesthesia

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview.
Start a Free Account
to access the full version.

Questions or Comment?

Also in This Category

Neuropathies associated with cytomegalovirus infection

Genital herpes: neurologic complications

Zika virus: neurologic complications

Distal myopathies

Gram-negative bacillary meningitis

Amyotrophic lateral sclerosis

Pneumococcal meningitis

HTLV-1 associated myelopathy

Post-polio syndrome

Introduction

Overview

Key points

Historical note and terminology

Clinical manifestations

Presentation and course

Table 1. Most Common New Late Manifestations of Poliomyelitis in Patients Referred to Post-polio Clinics*

Prognosis and complications

Biological basis

Etiology and pathogenesis

Epidemiology

Prevention

Differential diagnosis

Confusing conditions

Associated or underlying disorders

Diagnostic workup

Management

Table 2. Evidence-Based Treatment for Patients with Post-polio Syndrome*†

Special considerations

Anesthesia

References

Contributors

Author

Editor

Former Authors

Patient Profile

ICD & OMIM codes

This is an article preview. Start a Free Account to access the full version.

Questions or Comment?

Also in This Category

Neuropathies associated with cytomegalovirus infection

Genital herpes: neurologic complications

Zika virus: neurologic complications

Distal myopathies

Gram-negative bacillary meningitis

Amyotrophic lateral sclerosis

Pneumococcal meningitis

HTLV-1 associated myelopathy

This is an article preview.
Start a Free Account
to access the full version.